RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study

NCT02295566 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Nitric Oxide
DRUG: Control

Sponsor

University Hospital Southampton NHS Foundation Trust

Collaborators

[object Object]